BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26320482)

  • 21. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.
    Fleitas T; Martínez-Sales V; Vila V; Reganon E; Mesado D; Martín M; Gómez-Codina J; Montalar J; Reynés G
    Clin Transl Oncol; 2013 Nov; 15(11):897-902. PubMed ID: 23463593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
    de Jong C; Deneer VHM; Kelder JC; Ruven H; Egberts TCG; Herder GJM
    Thorac Cancer; 2020 Jul; 11(7):1790-1800. PubMed ID: 32383328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
    Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
    Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
    Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Kawaishi M; Fujiwara Y; Fukui T; Kato T; Yamada K; Ohe Y; Kunitoh H; Sekine I; Yamamoto N; Nokihara H; Watabe T; Shimoda Y; Arao T; Nishio K; Tamura T; Koizumi F
    J Thorac Oncol; 2009 Feb; 4(2):208-13. PubMed ID: 19179898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
    Kogure Y; Ando M; Saka H; Chiba Y; Yamamoto N; Asami K; Hirashima T; Seto T; Nagase S; Otsuka K; Yanagihara K; Takeda K; Okamoto I; Aoki T; Takayama K; Yamasaki M; Kudoh S; Katakami N; Miyazaki M; Nakagawa K
    J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib.
    Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O
    Anticancer Res; 2014 Jun; 34(6):3205-10. PubMed ID: 24922695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery.
    Li H; Tang K; Niu L; Liang Y; Li J; Chen J; Xu K
    Cancer Biomark; 2013; 13(5):337-43. PubMed ID: 24440973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
    Arunachalam A; Li H; Bittoni MA; Camacho R; Cao X; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e783-e799. PubMed ID: 29983370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer.
    Yan P; Han Y; Tong A; Liu J; Wang X; Liu C
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer.
    Kos FT; Hocazade C; Kos M; Uncu D; Karakas E; Dogan M; Uncu HG; Ozdemir N; Zengin N
    Asian Pac J Cancer Prev; 2015; 16(9):3997-4002. PubMed ID: 25987075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.
    Vilmar A; Santoni-Rugiu E; Cillas JG; Huarriz M; Sørensen JB
    Anticancer Res; 2014 Jun; 34(6):2991-6. PubMed ID: 24922664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of the C-erbB-2 expression in turkish non-small cell lung cancer patients.
    Calikusu Z; Yildirim Y; Akcali Z; Sakalli H; Bal N; Ozyilkan O
    Asian Pac J Cancer Prev; 2009; 10(3):479-82. PubMed ID: 19640195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
    Du ZY; Shi MH; Ji CH; Yu Y
    Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
    Okuma Y; Wakui H; Utsumi H; Sagawa Y; Hosomi Y; Kuwano K; Homma S
    Clin Lung Cancer; 2018 Sep; 19(5):410-417.e1. PubMed ID: 29859759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival predictors in advanced non-small cell lung cancer.
    Hespanhol V; Queiroga H; Magalhães A; Santos AR; Coelho M; Marques A
    Lung Cancer; 1995 Dec; 13(3):253-67. PubMed ID: 8719065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.